Web Editor, "Mad Money"
Savient Pharmaceuticals : "I still like it as much as I did at the beginning of the year ... I'm not backing away."
BioMarin Pharmaceutical : "I like [it]. I know people were disappointed with that last quarter. I think it's a mistake. BioMarin's a good biotech stock - and a takeover target."
MetroPCS Communications : "Let's not be too greedy. That stock has had a run." Cramer likes AT&T in this sector.
Questions? Comments? firstname.lastname@example.org